Kidney Transplant is the organ transplant of a healthy kidney into a patient
with serious renal disease. Kidney transplant is typically classified as
deceased-donor (formerly known as cadaveric) or living-donor transplant
depending on the source of the donor organ. Living-donor renal transplants are
further characterized as genetically related (living-related) or non-related
(living-unrelated) transplants, depending on whether a biological relationship
exists between the donor and recipient.
Most patients are concerned with how long can they live after kidney
transplant and can the disease be cured completely. The effect of kidney
transplant is generally marked with the survival rate of the kidney or the
person, which is usually one, three, five or ten years. Survival of kidney means
the kidney can play its function. Kidney transplant is earliest carried out in
China and has developed into a more mature technology.
The short-term treatment effect of kidney transplant is satisfying. Some
related materials show: In China, five years’ survival rate is more than 90% in
the 10 years’ survey of epidemiology. However, the long-term effect is not quite
good because more and more patients have been dead from renal death with
function and the number is 40% more than the death toll of kidney
transplant.
Experts point out that half-year later of the kidney transplant, most of the
patients with kidney transplant will gradually appear renal failure,
proteinuria, progressive anemia and renal size decreased of the transplanted
kidney etc and they will suffer transplant renal failure at any time. The
transplanted kidney would gradually lose its function in 6 months to years after
the operation, but the patients didn’t feel any discomfort. Form the point of
transplanting renal function, these operations are doubtless successful.
However, whatever the reasons are, if the patients are dead at last, all these
transplant operations seem to lose its meaning.
At present, what mainly threatens the patients with kidney transplant are
drug toxicity, cardiovascular diseases, virus infection, rejection reaction and
patients can not follow the doctor’s direction for a ling time. In clinic,
infection after transplant, especially CMV infection, has been the main problem
the doctors and patients are confronted with.
Suffering CMV infection after transplant may lead to many severe results,
such as increase the occurrence of acute or chronic rejection reaction,
cardiovascular diseases and Diabetes, reduce long-term survival rate and so on.
Among these results, cardiovascular diseases is the primary factor threatening
kidney transplant patients’ lives and about 50% of the kidney transplant
patients died from cardiovascular diseases. The key factor leading to
cardiovascular diseases is the occurrence of Hypertension and
Hypercholesterolemia after kidney transplant. Though the improvement of
anti-rejection drugs has greatly increased the survival rate of kidney
transplant patients, medical care, rational use of drugs, reasonable diet and
exercise and good living habit are as important as transplant operation.
According to statistics from related departments, 20 years’ survival rate of
patients with kidney transplant is rare, but the rate of Uremia patients taking
Dialyses and such kind conventional treatment method is 40%, which strongly
shows kidney transplant is not the best way to treat Uremia. At present, the
best way to treat Uremia is the combined therapy of Micro-Chinese Medicine Osmotherapy and Stem Cell Transplant, which can fundamentally block further
damage to kidneys, repair the damaged renal units and improve the renal
function. For Uremia patients in the end-stage, if they adopt Dialysis and
cooperate with dietary therapy and mental adjustment at the same time, their
life expectation can be increased and living quality can be improved.
If you have any inquiries, you can e-mail us:kidneyservice@hotmail.com and we
will make analysis for you.
没有评论:
发表评论